ADCYAP1 and diabetes mellitus: In conclusion, based on the functional, structural, and microvascular analysis, our study suggested that PACAP38 had a potent protective effect against developing diabetes and proved its power as a therapeutic approach to treat T2DRD in the form of eye drops.